News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
100 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (4321)
Month
January (2432)
February (1889)
Day
1 (32)
2 (100)
3 (113)
4 (139)
5 (216)
6 (52)
8 (27)
9 (94)
10 (156)
11 (131)
12 (218)
13 (41)
15 (20)
16 (35)
17 (163)
18 (191)
19 (161)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
Day
1
2
3
4
5
6
8
9
10
11
12
13
15
16
17
18
19
Press Releases
Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study
February 2, 2026
·
7 min read
Press Releases
TempraMed Enters Strategic Media Partnership with Dr. Phil’s Envoy Media, Validating Product Portfolio and Accelerating Market Adoption Across the United States
Access to an audience of over 19 million individuals monthly will expand national exposure, and supports scalable demand generation across B2C and B2B channels for TempraMed’s full product portfolio
February 2, 2026
·
6 min read
Press Releases
Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026
February 2, 2026
·
5 min read
Press Releases
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”
February 2, 2026
·
5 min read
Press Releases
IGC Pharma Reaches 70% Enrollment in Phase 2 CALMA Trial Evaluating IGC-AD1 for Alzheimer’s Agitation
February 2, 2026
·
3 min read
Press Releases
CorMedix Therapeutics Announces Share Repurchase Program
February 2, 2026
·
4 min read
Press Releases
Lupin Launches Dasatinib Tablets in the United States
February 2, 2026
·
2 min read
Press Releases
Mwyngil Therapeutics Announces Updates on NLRP3 Portfolio
February 2, 2026
·
2 min read
Press Releases
Sharp Therapeutics Announces Private Placement of up to US$3.0 Million in Unsecured Convertible Notes
February 2, 2026
·
6 min read
Press Releases
CD Genomics Launches Microbial Single-Cell Sequencing Service, Emerging as One of the Few Providers Capable of Unlocking “Microbial Dark Matter”
February 2, 2026
·
1 min read
Previous
10 of 10
